share_log

复星医药(600196.SH):复星健康、宁波复技拟与海南云志共同对复云健康进行增资

Shanghai Fosun Pharmaceutical (600196.SH): Fosun Health, Ningbo Fuji and Hainan Yunzhi jointly increase the capital of Fuyun Health.

Gelonghui Finance ·  Aug 12, 2022 19:10

Shanghai Fosun Pharmaceutical (600196.SH) announced that the company's holding subsidiaries Fosun Health and Ningbo Fuji plan to increase capital for Fuyun Health together with Hainan Yunzhi (Fuyun Health employee shareholding platform). Among them: Fosun Health plans to contribute 8.5 million yuan to subscribe for Fuyun Health increased registered capital of 8.5 million yuan, Ningbo compound Technology plans to contribute 8.5 million yuan to subscribe for Fuyun Health increased registered capital of 8.5 million yuan (that is, this investment). After the completion of this capital increase, the shareholder loan with a principal of RMB 25.5 million that Fosun Health has borrowed from Fosun Hi-Tech as of the date of this announcement will continue (that is, existing loan).

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment